Literature DB >> 204610

Recognition and destruction of target cells by tumoricidal macrophages.

I J Fidler.   

Abstract

Mesh:

Substances:

Year:  1978        PMID: 204610

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


× No keyword cloud information.
  22 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 2.  Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.

Authors:  A E Lagarde
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

3.  Activated monocytes kill malignant brain tumor cells in vitro.

Authors:  M Kirsch; H Fischer; G Schackert
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  Identification and characterization of a monoclonal antibody to an antigen expressed on activated macrophages.

Authors:  T P Koestler; D Rieman; K Muirhead; R G Greig; G Poste
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

5.  Preventing diversification of malignant tumor cells during therapy.

Authors:  G L Nicolson; R Lotan
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

Review 6.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

7.  Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro.

Authors:  C D Bucana; L C Hoyer; A J Schroit; E Kleinerman; I J Fidler
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

8.  Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects.

Authors:  A Faradji; A Bohbot; M Schmitt-Goguel; N Roeslin; S Dumont; M L Wiesel; C Lallot; M Eber; J Bartholeyns; P Poindron
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 9.  Inhibition of the arrest of hematogenously disseminated tumor cells.

Authors:  E Tsubura; T Yamashita; S Sone
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Systemic activation of macrophages by liposome-entrapped muramyl tripeptide in mice pretreated with the chemotherapeutic agent adriamycin.

Authors:  G Hisano; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.